Authors
Loading...
Systematic review reveals inconsistent reporting of disease risk and response criteria in clinical trials for myelodysplastic syndromes, highlighting a need for standardization.
Pugh et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: